Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

About Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.